News

News list

Announcement of New Shares through Third-Party Allotment

Jiksak Bioengineering, Inc. secures 170 Million JPY from ANRI, OHARA Pharmaceutical Co.,Ltd, Essential Pharma Co., Ltd. and MediFuture Co., Ltd. to co

Feb 21, 2018

ISSCR 2017@ Boston

At International Society for Stem cell research (ISSCR) 2017, Jiksak’s technologies was presented in the poster session.

Jun 14, 2017

Start Jiksak company

Jiksak Bioengineering Inc. was established in Hongo, Tokyo.

Feb 7, 2017